Contemporary Treatment Strategies in Pulmonary Hypertension: A Clinician's Guide.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 41115170.
- Also identified by DOI 10.1146/annurev-med-042623-013335 and PMC identifier 12614744.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Pulmonary hypertension (PH) is a complex condition characterized by pulmonary vasculopathy and progressive right ventricular dysfunction. Recent advances have reshaped PH management, including refined risk stratification, improved patient phenotyping, and the discovery of novel therapeutics. In alignment with the recommendations of the Seventh World Symposium on Pulmonary Hypertension, we summarize updated treatment strategies and emerging therapies, such as sotatercept, while acknowledging research gaps and areas of clinical equipoise. This practical, evidence-based review explores treatment across all groups of PH to inform clinical decision-making, improve long-term patient outcomes, and address both current and future challenges in PH management.
Medical subject headings
- Hypertension, Pulmonary